Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Opinion in Drug Discovery & Development|June 13, 2002
Progress in computational methods for the prediction of ADMET propertiesDavid E Clark, Peter D J GrootenhuisCurrent Topics in Medicinal Chemistry|May 29, 2003
Predicting passive transport in silico--history, hype, hopeDavid E Clark, Peter D J GrootenhuisDrug Discovery Today|October 26, 2005
High throughput P450 inhibition screens in early drug discoveryGregor Zlokarnik, Peter D J Grootenhuis, John B WatsonDrug Discovery Today. Technologies|July 2, 2014
In silico prediction of drug safety: despite progress there is abundant room for improvementWilliam J Egan, Gregor Zlokarnik, Peter D J GrootenhuisJournal of Medicinal Chemistry|September 19, 2003
Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonistsErin K Bradley, Jennifer L Miller, Eddine Saiah, et al.Journal of Medicinal Chemistry|April 19, 2002
A computational ensemble pharmacophore model for identifying substrates of P-glycoproteinJulie E Penzotti, Michelle L Lamb, Erik Evensen, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2004
Water-soluble molecular capsules: self-assembly and binding propertiesFrancesca Corbellini, Ronald M A Knegtel, Peter D J Grootenhuis, et al.Journal of Medicinal Chemistry|November 14, 2003
Comparing performance of computational tools for combinatorial library designErik Evensen, John E Eksterowicz, Robert V Stanton, et al.Journal of Medicinal Chemistry|May 31, 2002
Evaluation of a novel shape-based computational filter for lead evolution: application to thrombin inhibitorsJayashree Srinivasan, Angelo Castellino, Erin K Bradley, et al.Journal of Medicinal Chemistry|December 3, 2014
Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiatorSabine Hadida, Fredrick Van Goor, Jinglan Zhou, et al.Pageof 3